ALS Recovery

Symptom Relief

Find therapies and treatments to relieve the symptoms of ALS

Blogroll

Search


« | Home | »

Analysis Of Noteworthy Institutional 5% Ownership Filings For Wednesday And … – Seeking Alpha

By | January 26, 2012

Analysis Of Noteworthy Institutional 5% Ownership Filings For Wednesday And
Seeking Alpha
of a collaboration with Intrexon for Synthetic DNA-based therapy for PAH, and then positive clinical study results for its oral zinc compound in ALS, announced by its collaborator, the PNA Center for Neurological Research, in late-November.

Topics: Uncategorized | No Comments »

Comments